This week in Other Barks & Bites: the Federal Circuit affirms the invalidation of patent claims covering the rheumatoid arthritis treatment Enbrel using a novel argument on obviousness-type double patenting, and vacates a denial of attorney’s fees in a Southern Florida case which invalidated an asserted patent claim under Alice; the U.S. Patent and Trademark Office again extends relief on patent filing deadlines to small and micro entities under the CARES Act, launches a fast-track program to expedite ex parte appeals, and makes several other announcements; the U.S. Supreme Court denies cert to Chrimar v. ALE USA and issues a ruling finding that “generic.com” terms are not generic per se if consumers perceive them as a brand; an appeal to the Federal Circuit is alleging that PTAB judges are financially incentivized to grant validity reviews; and BIC wins a general exclusion order from the ITC preventing the importation of knock-off pocket lighters.
Patent
- Enablement
- Fee Shifting
- Litigation
- CAFC Gives Google Second Shot at PTAB in Challenge of Communications Patents
- Policy Shift Against SEP Rights Poses Risks for U.S. Innovation and Undermines Mandate of the ITC
- Mossoff-Barnett Comment on EU Commission’s Call for SEP Evidence Spotlights Misconceptions About FRAND Obligations
- LG’s Recent Infringement Fight Against TCL Could Take Some Tips from DivX’s Approach
- A Tale of Two Googles: Patent System Champion or Crux of the Problem?
Recent Posts
- CAFC Gives Google Second Shot at PTAB in Challenge of Communications Patents
- Policy Shift Against SEP Rights Poses Risks for U.S. Innovation and Undermines Mandate of the ITC
- Mossoff-Barnett Comment on EU Commission’s Call for SEP Evidence Spotlights Misconceptions About FRAND Obligations
- LG’s Recent Infringement Fight Against TCL Could Take Some Tips from DivX’s Approach
- A Tale of Two Googles: Patent System Champion or Crux of the Problem?